2m 2m 2m 2m 2m 2m 2m
IGC Pharma (IGC)
NYSE
$0.30-$0.007 (-2.27%)
Price as of Aug 21, 2026 7:50 PM EDT- $31.8MMarket Cap
- -15.62%1-Year Change
- BiotechnologyIndustry
IGC Pharma (IGC)
$0.30-$0.007 (-2.27%)
IGC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.31 | ||
Change | +$0.03 (+11.11%) | ||
Open | $0.29 | ||
High | $0.31 | ||
Low | $0.28 | ||
Previous Close | $0.28 | ||
Volume | 1,867,418 | ||
30-Day Average Volume | 783,520 | ||
1-Week Change | 3.43% | ||
1-Month Change | 15.31% | ||
1-Year Change | -15.62% | ||
3-Year Change | -7.26% | ||
5-Year Change | -79.87% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $9.5M | ||
Market Cap | $31.8M | ||
Enterprise Value | $32.6M | ||
Period: QTR TTM FY | |||
Revenue | $265,000.00 | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$1.4M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | -$2.0M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 123 | ||
P/B | 5 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/19/2013 | ||
Earnings & Revenue